deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT01185470

The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain

THE CLINICAL EVALUATION OF IMPLANTABLE PUMP SYSTEM FOR SAFETY AND DELIVERY ACCURACY IN PATIENTS REQUIRING INTRATHECAL ADMINISTRATION OF MORPHINE SULFATE FOR CHRONIC PAIN

Sponsor: Medallion Therapeutics, Inc.

Conditions Cancers Chronic Pain
Interventions Implantation of Morphine Sulfate delivering programmable pump
Updated 9 times since 2017 Last updated: Apr 20, 2017 Started: Feb 28, 2011 Primary completion: Jan 31, 2015 Completion: Jul 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01185470, this PHASE2/PHASE3 trial focuses on Cancers and Chronic Pain and remains completed. Sponsored by Medallion Therapeutics, Inc., it has been updated 9 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~May 2017 · 3 months · monthly snapshotActive Not Recruiting~May 2017 – ~Jun 2017 · 31 days · monthly snapshotUnknown Status~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3 → PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

▶ Show 4 earlier versions

  1. Jun 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    Status: Unknown Status → Completed

  2. May 2017 — Jun 2017 [monthly]

    Unknown Status PHASE2_PHASE3

    Status: Active Not Recruiting → Unknown Status

  3. Feb 2017 — May 2017 [monthly]

    Active Not Recruiting PHASE2_PHASE3

  4. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2_PHASE3

    First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medallion Therapeutics, Inc.
Data source: Medallion Therapeutics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations